stoxline Quote Chart Rank Option Currency Glossary
  
Conformis, Inc. (CFMS)
2.27  0.01 (0.44%)    09-01 15:57
Open: 2.26
High: 2.27
Volume: 7,081
  
Pre. Close: 2.26
Low: 2.25
Market Cap: 18(M)
Technical analysis
2023-10-20 4:22:35 PM
Short term     
Mid term     
Targets 6-month :  2.65 1-year :  3.09
Resists First :  2.26 Second :  2.65
Pivot price 2.26
Supports First :  2.25 Second :  2.24
MAs MA(5) :  2.25 MA(20) :  2.25
MA(100) :  1.81 MA(250) :  2.38
MACD MACD :  0 Signal :  0
%K %D K(14,3) :  50 D(3) :  50
RSI RSI(14): 68.8
52-week High :  6.97 Low :  1.04
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
[ CFMS ] has closed above bottom band by 43.3%. Bollinger Bands are 97.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 43 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 2.27 - 2.28 2.28 - 2.29
Low: 2.23 - 2.24 2.24 - 2.26
Close: 2.24 - 2.26 2.26 - 2.28
Company Description

Conformis, Inc., a medical technology company, develops, manufactures, and sells patient-specific products and instrumentation. The company offers personalized knee replacement products, including iUni, iDuo, a custom-made partial knee replacement option for either unicompartmental or bicompartmental osteoarthritis of the knee; iTotal CR, a cruciate retaining total knee replacement product; iTotal PS, a posterior stabilized knee replacement product, as well as provides iTotal Identity and Identity Imprint knee replacement products. It also provides Conformis Hip System and Cordera hip replacement, which are hip replacement products; and iJigs, a personalized single-use patient-specific instrumentation. The company markets and sells its products to orthopedic surgeons, hospitals, and other medical facilities through sales force, independent sales representatives, and distributors in the United States, Germany, the United Kingdom, Austria, Ireland, Switzerland, Spain, Portugal, the Netherlands, Belgium, the Dutch Antilles, Suriname, Australia, the United Arab Emirates, the Sultanate of Oman, Italy, Poland, and other markets. Conformis, Inc. was incorporated in 2004 and is headquartered in Billerica, Massachusetts.

Headline News

Fri, 22 Mar 2024
ConforMIS (CFMS) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Canada Shine On

Mon, 18 Mar 2024
ConforMIS (CFMS) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Movies UK

Sun, 03 Mar 2024
ConforMIS (CFMS) Moves to Buy: Rationale Behind the Upgrade - Yahoo Canada Shine On

Tue, 05 Sep 2023
restor3d Completes Acquisition of Conformis - OrthoSpineNews

Thu, 20 Jul 2023
There's No Escaping Conformis, Inc.'s (NASDAQ:CFMS) Muted Revenues Despite A 86% Share Price Rise - Yahoo Finance

Fri, 23 Jun 2023
Restor3d to acquire Conformis for $2.27 per share - Mass Device

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Underperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Neutral
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Outperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Outperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Medical - Devices
Shares Out 8 (M)
Shares Float 7 (M)
Held by Insiders 6.2 (%)
Held by Institutions 22.5 (%)
Shares Short 84 (K)
Shares Short P.Month 111 (K)
Stock Financials
EPS -5.7
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 4.07
Profit Margin -72.8 %
Operating Margin -70.9 %
Return on Assets (ttm) -27.4 %
Return on Equity (ttm) -78.8 %
Qtrly Rev. Growth -14.9 %
Gross Profit (p.s.) 2.94
Sales Per Share 7.24
EBITDA (p.s.) -4.66
Qtrly Earnings Growth 0 %
Operating Cash Flow -45 (M)
Levered Free Cash Flow -31 (M)
Stock Valuations
PE Ratio -0.4
PEG Ratio 0
Price to Book value 0.55
Price to Sales 0.31
Price to Cash Flow -0.4
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android